Thus, targeting serpins or enhancing plasmin production in the tumor microenvironment awaits further exploration to limit the adherence of cancer cells to the existing vessels, thereby preventing the formation of vessel co-opted tumors. The gene discussed is PLG; the disease is neoplasm.